Recruiting

Observational StudyRegister for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study

Sponsor:

UCLA

Code:

NCT00616317

Conditions

Antiphospholipid Syndrome

Eligibility Criteria

Sex: All

Age: 0 - 18

Healthy Volunteers: Not accepted

Study Details

Brief summary:

The purpose of this study is to gather information about causes and treatment of Antiphospholipid Syndrome.

Conditions

Antiphospholipid Syndrome

Study ID

NCT00616317

Start date

Sep, 2006

Status verified date

Dec, 2025

Completion date

Jan, 2040

Anticipated

Primary completion date

Jan, 2040

Anticipated

Eligibility Criteria

Sex: All

Age: 0 - 18

Healthy Volunteers: Not accepted

Inclusion Criteria:

18 years of age or younger at the onset of disease
Presence of Vascular Thrombosis
UC Davis patient
Presence of at least one Laboratory criteria including: Anticardiolipin antibody, Anti-B glycoprotein-I antibody or Lupus anticoagulant in plasma

Exclusion Criteria:

Infants born to mothers with APS
Infants with congenital thrombophilia

Study Design

Enrollment

50 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

Long term survival [ Time Frame: 10 year ]

Central Contacts and Locations

Central contacts

Lavjay Butani

(916) 734-8118

Locations

UC Davis Medical Center

Recruiting

Sacramento, California, United States, 95817

More Information

Sponsor

University of California, Davis

Last update posted

Dec 5, 2025

Last verified

Dec, 2025

Keywords

Antiphospholipid Syndrome

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of California, Davis on 2025-12-05.